DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy-Reference-Cited by-同舟云学术

DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy

Published:2013-12-19 Issue:1 Volume:41 Page:011708
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

Farjam Reza,Tsien Christina I.,Lawrence Theodore S.,Cao Yue

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Medicine

Reference31 articles.

1. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology

2. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging;Jackson;Clin. Cancer Res.,2007

3. Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples;Yankeelov;Curr. Med. Imaging Rev.,2007

4. Estimating kinetic parameters from dynamic contrast enhanced T1 -weighted MRI of a diffusible tracer: Standardized quantities and symbols;Tofts;J. Magn. Reson. Imaging,1999

5. Assessing changes in tumor vascular function using dynamic contrast-enhanced magnetic resonance imaging;Hayes;NMR Biomed.,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis;Neuro-Oncology Advances;2021-01-01

2. Classification of true progression after radiotherapy of brain metastasis on MRI using artificial intelligence: a systematic review and meta-analysis;Neuro-Oncology Advances;2021-01-01

3. The transformation of radiation oncology using real-time magnetic resonance guidance: A review;European Journal of Cancer;2019-11

4. PET and MRI based RT treatment planning: Handling uncertainties;Cancer/Radiothérapie;2019-10

5. Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers;Tomography;2019-03-01